Literature DB >> 35067815

The significance of the SDF-1/CXCR4 signaling pathway in the normal development.

Farzad Sadri1, Zohreh Rezaei2,3, Mohammad Fereidouni4,5.   

Abstract

Chemokines are chemoattractants that can regulate cell movement and adhesion. SDF-1 [stromal cell-derived factor-1 (SDF-1)] is a homeostatic CXC chemokine. SDF-1 and its receptors [CXC chemokine receptor 4 (CXCR4)] form a signaling pathway that plays critical roles in different pathological and physiological mechanisms, including embryogenesis, wound healing, angiogenesis, tumor growth, and proliferation. Therefore, the current review aimed to summarize the related studies that addressed the molecular signature of the SDF-1/CXCR4 pathway and to explain how this axis is involved in normal events.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  CXCR4; Chemokines; Migration; SDF-1; Stem cells

Mesh:

Substances:

Year:  2022        PMID: 35067815     DOI: 10.1007/s11033-021-07069-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  95 in total

Review 1.  Chemokines: a new classification system and their role in immunity.

Authors:  A Zlotnik; O Yoshie
Journal:  Immunity       Date:  2000-02       Impact factor: 31.745

Review 2.  The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis.

Authors:  M Z Ratajczak; E Zuba-Surma; M Kucia; R Reca; W Wojakowski; J Ratajczak
Journal:  Leukemia       Date:  2006-08-10       Impact factor: 11.528

Review 3.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.

Authors:  S F Altschul; T L Madden; A A Schäffer; J Zhang; Z Zhang; W Miller; D J Lipman
Journal:  Nucleic Acids Res       Date:  1997-09-01       Impact factor: 16.971

Review 4.  CXCL12 (SDF-1)/CXCR4 pathway in cancer.

Authors:  Beverly A Teicher; Simon P Fricker
Journal:  Clin Cancer Res       Date:  2010-05-18       Impact factor: 12.531

Review 5.  New paradigms in chemokine receptor signal transduction: Moving beyond the two-site model.

Authors:  Andrew B Kleist; Anthony E Getschman; Joshua J Ziarek; Amanda M Nevins; Pierre-Arnaud Gauthier; Andy Chevigné; Martyna Szpakowska; Brian F Volkman
Journal:  Biochem Pharmacol       Date:  2016-04-19       Impact factor: 5.858

6.  Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization.

Authors:  Jun-ichi Yamaguchi; Kengo Fukushima Kusano; Osamu Masuo; Atsuhiko Kawamoto; Marcy Silver; Satoshi Murasawa; Marta Bosch-Marce; Haruchika Masuda; Douglas W Losordo; Jeffrey M Isner; Takayuki Asahara
Journal:  Circulation       Date:  2003-03-11       Impact factor: 29.690

7.  Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1.

Authors:  M P Crump; J H Gong; P Loetscher; K Rajarathnam; A Amara; F Arenzana-Seisdedos; J L Virelizier; M Baggiolini; B D Sykes; I Clark-Lewis
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

Review 8.  Chemokine and chemokine receptor structure and interactions: implications for therapeutic strategies.

Authors:  Irina Kufareva; Catherina L Salanga; Tracy M Handel
Journal:  Immunol Cell Biol       Date:  2015-02-24       Impact factor: 5.126

9.  Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene.

Authors:  M Shirozu; T Nakano; J Inazawa; K Tashiro; H Tada; T Shinohara; T Honjo
Journal:  Genomics       Date:  1995-08-10       Impact factor: 5.736

Review 10.  Chemokine receptors: multifaceted therapeutic targets.

Authors:  Amanda E I Proudfoot
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

View more
  1 in total

1.  Antiviral Activity of a Cyclic Pro-Pro-β3-HoPhe-Phe Tetrapeptide against HSV-1 and HAdV-5.

Authors:  Ewa Zaczyńska; Krzysztof Kaczmarek; Janusz Zabrocki; Jolanta Artym; Michał Zimecki
Journal:  Molecules       Date:  2022-05-31       Impact factor: 4.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.